RTW Investments OMDA Position
Active5-Fund ConvergenceRTW Investments held their position in Omada Health, Inc. (OMDA) in Q4 2025, holding $3.2M worth of shares across 200,000 shares.
The position was first reported in Q2 2025 and has been tracked across 3 quarterly 13F filings.
OMDA is a convergence signal: 5 specialist biotech funds hold this stock, suggesting high institutional conviction.
About Omada Health, Inc.
Omada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.
Full company profile →Short Interest
5.3%
1.7 days to cover
RTW Investments OMDA Position History
Frequently Asked Questions
Does RTW Investments own OMDA?
Yes. As of Q4 2025, RTW Investments holds 200,000 shares of Omada Health, Inc. (OMDA) valued at $3.2M. This data comes from their SEC 13F filing.
How many hedge funds own OMDA?
5 specialist biotech hedge funds currently hold OMDA, including Perceptive Advisors, Rock Springs Capital, Deerfield Management and 1 more. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did RTW Investments first buy OMDA?
RTW Investments's position in OMDA was first reported in Q2 2025. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is RTW Investments's OMDA position increasing or decreasing?
RTW Investments held their OMDA position unchanged in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
OMDACompany Page →
All fund holders, insider trades, catalysts, and cash runway
RTW InvestmentsPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →